Skip to content

US · ENSG · MEDICAL - CARE FACILITIES

The Ensign Group, Inc. (ENSG) intrinsic value and stock valuation

$176.32as of 2026-11-21 · Mkt cap 10.66B

Data updated · price as of 2026-11-21

OvervaluedIC value is 20–50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

The Ensign Group, Inc. DCF and intrinsic value

InvestorsCraft values ENSG with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from ENSG’s statements →

The Ensign Group, Inc. Graham Number

Graham Number: $72.57d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities San Juan Capistrano, CA 92675 ensigngroup.net

How the business is doing

Fiscal 2011–2025, USD

Revenue
$5.06B+16.1% 5y CAGRd
20112025
Net income
$344M+15.1% 5y CAGRd
20112025
Free cash flow
$370.7M+2.8% 5y CAGRd
20112025
Total equity
$2.23B+22.3% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$5.06B$4.26B$3.73B$3.03B$2.63B
Operating income$425.3M$358.3M$255.4M$296.8M$260.5M
Net income$344M$298M$209.4M$224.7M$194.7M
EPSd$5.84M$5.12M$3.65M$3.95M$3.42M
Operating cash flow$564.3M$347.2M$376.7M$272.5M$275.7M
Capital expenditure-$-193.56M-$-158.24M-$-106.18M-$-87.55M-$-69.55M
Free cash flow$370.7M$189M$270.5M$185M$206.1M
Total assets$5.46B$4.67B$4.18B$3.45B$2.85B
Total debt$4.16B$1.97B$1.87B$1.57B$1.27B
Net debt$3.65B$1.51B$1.36B$1.26B$1B
Total equity$2.23B$1.84B$1.5B$1.25B$1.02B
Cash and short-term investments$572.4M$526.9M$526.9M$331.7M$276M
Income statement
20252024202320222021
Revenue$5.06B$4.26B$3.73B$3.03B$2.63B
Cost of revenue$4.26B$3.59B$3.14B$2.51B$2.16B
Gross profit$799.5M$667.6M$590.8M$518M$468.2M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$269.8M$225.1M$263M$158.8M$151.8M
Other expenses$104.3M$84.1M$72.4M$62.4M$56M
Operating expenses$374.2M$309.3M$335.4M$221.2M$207.8M
Cost and expenses$4.63B$3.9B$3.47B$2.73B$2.37B
Interest income$24.5M$28.8M$19.2M$5.04M$4.39M
Interest expense$7.99M$8.29M$8.09M$8.93M$6.85M
Depreciation and amortization$104.3M$84.1M$72.4M$62.4M$56M
Ebitda$567.9M$478.5M$353.2M$360.4M$320.8M
Operating income$425.3M$358.3M$255.4M$296.8M$260.5M
Total other income/expenses, net$30.3M$27.8M$17.4M-$-7.74M-$-2.46M
Income before tax$455.6M$386.1M$272.8M$289.1M$258M
Income tax expense$111.4M$87.6M$62.9M$64.4M$60.3M
Net income$344M$298M$209.4M$224.7M$194.7M
Weighted average shares outstanding$57.3M$56.7M$55.7M$54.9M$54.5M
Weighted average diluted shares outstanding$58.9M$58.2M$57.3M$56.9M$56.9M
Balance sheet
20252024202320222021
Cash and short-term investments$572.4M$526.9M$526.9M$331.7M$276M
Net receivables$637M$569.9M$485M$408.4M$328.7M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$1.27B$1.16B$1.05B$781.1M$639.7M
Property, plant and equipment, net$3.79B$3.15B$2.85B$2.44B$2.03B
Goodwill and intangible assets$104.4M$105.3M$83.4M$83.3M$66.9M
Long-term investments$166.8M$0.00$0.00$0.00$0.00
Total non-current assets$4.19B$3.51B$3.13B$2.67B$2.21B
Total assets$5.46B$4.67B$4.18B$3.45B$2.85B
Accounts payable$97.3M$99M$92.8M$77.1M$58.1M
Short-term debt$119M$97.6M$86.5M$69.7M$55.9M
Deferred revenue$105.6M$18.8M$10.8M$9.7M$9.34M
Total current liabilities$894.4M$743.4M$734.8M$582.1M$523.1M
Long-term debt$4.04B$1.88B$1.78B$1.5B$1.21B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$2.33B$2.09B$1.95B$1.62B$1.31B
Capital lease obligations$2.06B$1.83B$1.72B$1.42B$1.11B
Total liabilities$3.23B$2.83B$2.68B$2.2B$1.83B
Common stock$60K$60K$60K$60K$60K
Retained earnings$1.76B$1.43B$1.14B$946.3M$734M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$2.23B$1.84B$1.5B$1.25B$1.02B
Total investments$235.4M$62.3M$17.2M$15.4M$13.8M
Total debt$4.16B$1.97B$1.87B$1.57B$1.27B
Net debt$3.65B$1.51B$1.36B$1.26B$1B
Cash flow statement
20252024202320222021
Net income$344.3M$298.5M$209.9M$224.7M$197.7M
Depreciation and amortization$104.3M$84.1M$72.4M$62.4M$56M
Stock-based compensation$48.3M$36.2M$30.8M$22.7M$18.7M
Change in working capital$77.9M-$-75.16M$37.9M-$-36.94M$30K
Accounts receivable-$-70.43M-$-84.4M-$-79.82M-$-82.43M-$-30.77M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable-$-2.92M$2.83M$15.9M$17.9M$7.12M
Net cash provided by operating activities$564.3M$347.2M$376.7M$272.5M$275.7M
Investments in property, plant and equipment-$-193.56M-$-158.24M-$-106.18M-$-87.55M-$-69.55M
Acquisitions, net$0.00$0.00$0.00-$-16.4M-$-7.98M
Net cash used for investing activities-$-513.18M-$-390.05M-$-182.7M-$-186.18M-$-173.91M
Common stock issued$29M$0.00$0.00$6.69M$0.00
Common stock repurchased-$-21.43M-$-1.21M-$-1.93M-$-31.58M-$-11.83M
Dividends paid-$-14.41M-$-13.67M-$-12.89M-$-12.17M-$-11.55M
Net cash used for financing activities-$-11.81M-$-2.16M-$-610K-$-32.26M-$-76.14M
Net change in cash$39.3M-$-45.03M$193.4M$54.1M$25.6M
Cash at end of period$503.9M$464.6M$509.6M$316.3M$262.2M
Operating cash flow$564.3M$347.2M$376.7M$272.5M$275.7M
Capital expenditure-$-193.56M-$-158.24M-$-106.18M-$-87.55M-$-69.55M
Free cash flow$370.7M$189M$270.5M$185M$206.1M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About The Ensign Group, Inc.

        The Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care. This division also encompasses a variety of rehabilitative therapies, such as physical, occupational, and speech therapy, among other specialized healthcare provisions. Beyond direct medical care, the company furnishes essential amenities like lodging, customized dietary programs, and opportunities for social engagement, recreation, and entertainment. Ensign additionally manages senior living facilities and delivers convenient mobile diagnostic services. Its diverse array of supplementary services includes digital X-rays, ultrasounds, electrocardiograms, laboratory analyses, sub-acute care, and patient transportation, which can be provided either in patients' residences or at long-term care facilities. The company also engages in the leasing of real estate properties. As of April 4, 2022, Ensign operated a network of 252 healthcare facilities spread across thirteen U.S. states: Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The Ensign Group, Inc. was established in 1999 and is headquartered in San Juan Capistrano, California.

        CEO
        Barry R. Port
        Employees
        46K
        Beta
        0.69

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of The Ensign Group, Inc. (ENSG)?

        The Ensign Group, Inc. (ENSG) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is ENSG undervalued?

        ENSG trades at a price of $176.32 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.